Clinical analysis and follow-up study of cardiavascular system involvement in 10 children with methylmalonic aciduria combined with hyperhomocysteinemia
QI Yan-Hua, QI Jian-Guang, LIU Yu-Peng, YAN Hui, LIU Xue-Qin, ZHANG Xin, XIAO Hui-Jie, YANG Yan-Ling, DU Jun-Bao
Department of Pediatrics, First Hospital of Peking University, Beijing 100034, China
Abstract Objective To study the clinical features and treatment outcomes of cardiovascular system involvement in children with methylmalonic aciduria combined with hyperhomocysteinemia (MMACHC).Methods The clinical data of 10 children with methylmalonic aciduria combined with hyperhomocysteinemia and who had cardiovascular system involvement were retrospectively analyzed and the treatment outcomes were followed up.Results In the 10 patients, there were 4 cases with initial presentations of cardiovascular system symptoms such as shortness of breath and dyspnea, 3 cases with urinary tract symptoms such as edema, hematuria and proteinuria, and 3 cases with nervous system symptoms such as developmental retardation and convulsions. The 10 patients had different types and severity of cardiovascular injuries. After 3 months to 8 years of follow-up, the congenital heart defects resolved naturally in 2 cases, and the patient with arrhythmia had no obvious changes. In 5 cases of hypertension, blood pressures recovered to normal in 3 cases, and 1 case was lost to follow-up. In 5 patients with pulmonary hypertension, 2 died, 2 recovered, and 1 case had mildly elevated pulmonary artery pressure. Seven patients underwent MMACHC gene testing, and 5 showed c.80A>G mutations.Conclusions Metabolic disease should be taken into account for the children with unexplained pulmonary hypertension and hypertension with the onset of the shortness of breath and dyspnea. The severity of cardiovascular system involvement might be one of the most important factors affecting the prognosis of children with MMACHC. Cardiavascular system involvement of the patients may be related to MMACHC c.80A>G mutations.
QI Yan-Hua,QI Jian-Guang,LIU Yu-Peng et al. Clinical analysis and follow-up study of cardiavascular system involvement in 10 children with methylmalonic aciduria combined with hyperhomocysteinemia[J]. CJCP, 2015, 17(9): 965-970.
QI Yan-Hua,QI Jian-Guang,LIU Yu-Peng et al. Clinical analysis and follow-up study of cardiavascular system involvement in 10 children with methylmalonic aciduria combined with hyperhomocysteinemia[J]. CJCP, 2015, 17(9): 965-970.
Wang X, Sun W, Yang Y, et al. A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in China[J]. J Neurol Sci, 2012, 318(1-2):155-159.
[3]
Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonicacidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management[J]. J Inherit Metab Dis, 2012, 35(1):91-102.
[4]
Profitlich LE, Kirmse B, Wasserstein MP, et al. High prevalence of structural heart disease in children with cblCtype methylmalonic aciduria and homocystinuria[J]. Mol Genet Metab, 2009, 98(4):344-348.
[5]
Prada CE, Kirk EP, Hopp M, et al. Cardiac disease in methylmalonicacidemia[J]. J Pediatr, 2011, 159(5):862-864.
[6]
GündüzM1, Ekici F, Ozaydın E, et al. Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene[J]. Eur J Pediatr, 2014, 173(12):1707-1710.
[7]
Profitlich L, Kirmse B, Wasserstein MP, et al. Resolution of corpulmonale after medical management in a patient with cblC-type methylmalonic aciduria and homocystinuria:a case report[J]. Cases J, 2009, 2:8603.
[8]
De Bie I, Nizard SD, Mitchell GA. Fetal dilated cardiomyopathy:an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, cblC type[J]. Prenat Diagn, 2009, 29(3):266-270.
[9]
Fu XW, Xu YK, Chan P, et al. Simple, fast, and simultaneous detection of plasma total homocysteine, methylmalonic acid, methionine, and 2-methylcitric acid using liquid chromatography and mass spectrometry (LC/MS/MS)[J]. JIMD Rep, 2013, 10:69-78.
Cornec-Le GE, Delmas Y, De Parscau L, et al. Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency[J]. Am J Kidney Dis, 2014, 63(1):119-123.
Tu WJ, Chen H, He J. Methylmalonic aciduria:newborn screening in mainland China[J]. J Pediatr Endocrinol Metab, 2013, 26(3-4):399-400.
[14]
Richard E, Desviat LR, Ugarte M, et al. Oxidative stress and apoptosis in homocystinuria patients with genetic remethylation defects[J]. J Cell Biochem, 2013, 114(1):183-191.
[15]
Joseph J, Loscalzo J. Methoxistasis:integrating the roles of homocysteine and folic acid in cardiovascular pathobiology[J]. Nutrients, 2013, 5(8):3235-3256.
